An Atypical Neuroleptic Drug in the Treatment of Behavioural Disturbances and Psychotic Symptoms in Elderly People
- 23 April 1996
- journal article
- clinical trial
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 7 (3) , 142-146
- https://doi.org/10.1159/000106869
Abstract
The present study is a retrospective study of remoxipride therapy. A total of 103 patients, 65 years or older, with a DSM-III-R diagnosis of dementia or delirium, were included. They had all been treated with remoxipride because of psychotic symptoms or behavioural disturbances. The dose range of remoxipride was 50-300 mg, the median dose being 75 mg. The clinical effect was rated as good in two thirds of the patients, and side-effects were noted in one fourth. When psychomotor hyperactivity was the dominating problem, a good effect was rated in 81 % of the patients. Side-effects were few and mild, the most common being tiredness; only 5 patients showed extrapyramidal symptoms.Keywords
This publication has 0 references indexed in Scilit: